Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Korom

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Transplantation Proceedings|August 15, 2002
Gemcitabine in models of acute and accelerated rejectionF Jung, S Wilker, E Maas, et al.
Transplantation Proceedings|February 1, 1997
Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipientsA J Coito, S Korom, L Van de Water, et al.
The European Respiratory Journal|October 21, 2009
A model of chronic lung allograft rejection in the ratW Jungraithmayr, P Vogt, I Inci, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Evidence against a pivotal role of preformed antibodies in delayed rejection of a guinea pig-to-rat heart xenograftH Grimm, P Mages, G Lindemann, et al.
Transplantation Proceedings|March 27, 2001
Complement inactivated, preformed antibodies do not play a pivotal role in delayed rejection of a guinea pig-to-rat cardiac xenograftH Grimm, P Mages, G Lindemann, et al.
Transplantation|January 9, 1998
CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipientsT H Stadlbauer, M Schaub, S Korom, et al.
The Annals of Thoracic Surgery|November 28, 2001
Accelerated treatment for early and late postpneumonectomy empyemaD Schneiter, P Cassina, S Korom, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 31, 2016
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implicationsD Robinson, M Humbert, R Buhl, et al.
Transplantation Proceedings|February 1, 1997
The effects of CD26/DPP IV-targeted therapy on acute allograft rejectionS Korom, I De Meester, K Onodera, et al.
Transplantation|April 1, 1998
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expressionA J Coito, S Korom, E Graser, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Transplantation Proceedings|August 15, 2002
Gemcitabine in models of acute and accelerated rejectionF Jung, S Wilker, E Maas, et al.
Transplantation Proceedings|February 1, 1997
Distinct fibronectin splicing variants: potential targets for therapeutic immunomodulation in organ allograft recipientsA J Coito, S Korom, L Van de Water, et al.
The European Respiratory Journal|October 21, 2009
A model of chronic lung allograft rejection in the ratW Jungraithmayr, P Vogt, I Inci, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 2000
Evidence against a pivotal role of preformed antibodies in delayed rejection of a guinea pig-to-rat heart xenograftH Grimm, P Mages, G Lindemann, et al.
Transplantation Proceedings|March 27, 2001
Complement inactivated, preformed antibodies do not play a pivotal role in delayed rejection of a guinea pig-to-rat cardiac xenograftH Grimm, P Mages, G Lindemann, et al.
Transplantation|January 9, 1998
CD28-B7 T-cell co-stimulatory blockade potentiates the effects of intrathymic immunomodulation in sensitized graft recipientsT H Stadlbauer, M Schaub, S Korom, et al.
The Annals of Thoracic Surgery|November 28, 2001
Accelerated treatment for early and late postpneumonectomy empyemaD Schneiter, P Cassina, S Korom, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|December 31, 2016
Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implicationsD Robinson, M Humbert, R Buhl, et al.
Transplantation Proceedings|February 1, 1997
The effects of CD26/DPP IV-targeted therapy on acute allograft rejectionS Korom, I De Meester, K Onodera, et al.
Transplantation|April 1, 1998
Blockade of very late antigen-4 integrin binding to fibronectin in allograft recipients: I. Treatment with connecting segment-1 peptides prevents acute rejection by suppressing intragraft mononuclear cell accumulation, endothelial activation, and cytokine expressionA J Coito, S Korom, E Graser, et al.
Pageof 4